While 91.99 ± 3.5% of NDN and 65.56 ± 6.71% of LDN expressed CXCR2 in a 4T1 tumor model (Figure 2A), only 1.80 ± 1.21% of TANs showed such expression. Here, CXCR2 is linked to neoplasm.